-
July 28: The Week in Cancer News
Less than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.
by Thomas Celona
-
July 21: The Week in Cancer News
ASCO guideline emphasizes the importance of assessment for older cancer patients, and a change in mammogram recommendations reignites screening debates.
by Eric Fitzsimmons
-
July 14: The Week in Cancer News
Black men with melanoma have higher risk of dying, and CAR T-cell therapy provides hope for aggressive lymphoma.
by Marci A. Landsmann
-
After Colorectal Cancer, Survivors Face Higher Risk for a Second Cancer
Researchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
July 7: The Week in Cancer News
Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.
by Kevin McLaughlin
-
Susan Love, Breast Surgeon and Patient Advocate, Dies at 75
Love co-wrote Dr. Susan Love’s Breast Book and was vocal in promoting improved breast cancer diagnosis and treatment.
by Kevin McLaughlin
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona